Article Versions Notes

Feng JY, Du Pont V, Babusis D, Gordon CJ, Tchesnokov EP, Perry JK, Duong V, Vijjapurapu A, Zhao X, Chan J, et al. The Nucleoside/Nucleotide Analogs Tenofovir and Emtricitabine Are Inactive against SARS-CoV-2. Molecules. 2022; 27(13):4212. https://doi.org/10.3390/molecules27134212

Feng, Joy Y., Venice Du Pont, Darius Babusis, Calvin J. Gordon, Egor P. Tchesnokov, Jason K. Perry, Vincent Duong, Arya Vijjapurapu, Xiaofeng Zhao, Julie Chan, and et al. 2022. "The Nucleoside/Nucleotide Analogs Tenofovir and Emtricitabine Are Inactive against SARS-CoV-2" Molecules 27, no. 13: 4212. https://doi.org/10.3390/molecules27134212

Feng, J. Y., Du Pont, V., Babusis, D., Gordon, C. J., Tchesnokov, E. P., Perry, J. K., Duong, V., Vijjapurapu, A., Zhao, X., Chan, J., Cohen, C., Juneja, K., Cihlar, T., Götte, M., & Bilello, J. P. (2022). The Nucleoside/Nucleotide Analogs Tenofovir and Emtricitabine Are Inactive against SARS-CoV-2. Molecules, 27(13), 4212. https://doi.org/10.3390/molecules27134212